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Abstract
Meroterpenoids are natural products produced from polyketide and terpenoid precursors. A gene
targeting system for A. terreus NIH2624 was developed and a gene cluster for terretonin
biosynthesis was characterized. The intermediates and shunt products were isolated from the
mutant strains and a pathway for terretonin biosynthesis is proposed. Analysis of two
meroterpenoid pathways corresponding to terretonin in A. terreus and austinol in A. nidulans
reveals that they are closely related evolutionarily.
Filamentous fungi are known to produce a wide variety of secondary metabolites. Genome
sequencing of members of the genus Aspergillus revealed that there are more secondary
metabolite gene clusters than known secondary metabolites, suggesting that more secondary
metabolites could be discovered from these organisms. These metabolites display a broad
spectrum of biological activity. One example is lovastatin from Aspergillus terreus, which
became the first cholesterol-lowering drugof its class approved for human use in the United
States.1
Terretonin, a mycotoxin identified from A. terreus, belongs to a structurally complex class
of natural products called meroterpenoids (Figure 1).2 Pioneering work by Simpson and
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Vederas in the 1980s using labeled precursors demonstrated that terretonin is produced by
both polyketide and terpenoid biosynthetic pathways.3-5
Recently, the function of the polyketide synthase (PKS) gene, the prenyltransferase (PT)
gene and the epoxidase gene involved in terretonin biosynthesis were ascertained via
expressing the above genes in A. oryzae.6 Whereas the biosynthetic genes for terretonin are
clustered in one discrete unit, we identified two separate clusters required for the formation
of the meroterpenoid austinol in A. nidulans, one containing four genes including the PKS
ausA, and the other containing ten additional genes including the PT gene ausN.7 This case
represents one of the few examples in fungi in which more than one cluster is responsible
for the biosynthesis of a particular natural product.7-9
Herein we present a bioinformatic analysis of A. terreus NIH2624 and identified a putative
gene cluster for terretonin biosynthesis. We identified six secondary metabolites from A.
terreus NIH2624 including terretonin (1),10 terretonin C (2),11 asterrelenin (3),11
butyrolactone III (4),12 epi-aszonalenin A (5),13 and butyrolactone I (6)14 [Figure 1; NMR
data available in Supporting Information (SI)]. We identified 31 PKS genes in A. terreus15
and narrowed the search to the nine nonreducing PKSs (NRPKS) that produce the aromatic
polyketides.16 Since secondary metabolite genes in Aspergilli are often clustered,17 we
examined genes surrounding these nine NR-PKS genes to locate an NR-PKS that is close to
a PT gene. This bioinformatic analysis indicated that the NRPKS ATEG_10080.1 and the
adjacent putative PT ATEG_10078.1 are most likely involved in terretonin biosynthesis. To
confirm their involvement, we selected these genes for deletion experiments.
We then developed a transformation system based on methods developed for A. niger.18 A
knock out cassette was constructed using a fusion PCR approach19 and ATEG_10080.1 and
ATEG_10078.1 were replaced with the hph marker via homologous recombination. Indeed,
only the production of terretonin (1) and terretonin C (2) was eliminated in ATEG_10080.1
and ATEG_10078.1 deletant strains (Figure 1). Only 3,5-dimethylorsellinic acid (DMOA,
7), which is the polyketide precursor in terretonin biosynthesis accumulated in
ATEG_10078.1Δ (Figure 1). Our results are consistent with previous results shown by Itoh
et al.6 For consistency we have used the same gene nomenclature as set forth by Itoh et al.
and labeled ATEG_10080.1 and ATEG_10078.1 as trt4 and trt2, respectively (Figure 2).
To explicitly characterize this cluster, an additional thirteen genes from ATEG_10075.1 to
ATEG_10089.1 that are in proximity to trt4, were individually deleted. Examination of the
LC/MS profiles revealed that ATEG_10077.1Δ (trt1Δ), ATEG_10079.1Δ (trt3Δ),
ATEG_10081.1Δ (trt5Δ), ATEG_10082.1Δ (trt14Δ), ATEG_10083.1Δ (trt6Δ),
ATEG_10084.1Δ (trt7Δ), ATEG_10085.1Δ (trt8Δ) and ATEG_10086.1Δ (trt9Δ) impaired
the production of either terretonin (1) or terretonin C (2) or both (Figure 1 and 2).
ATEG_10082.1 was not included in the trt cluster predicted by Itoh et al.6 Since this gene
was shown to be involved, we labeled it as trt14. ATEG_10087.1 (trt11), ATEG_10088.1
(trt12) and ATEG_10089.1 (trt13) were predicted by Itoh et al. to be involved although no
experimental data were shown to verify the prediction.6 Terretonins (1 and 2) were produced
in the trt11Δ, trt12Δ and trt13Δ mutant strains we generated (Figure 1), indicating that these
genes are not involved and they define one end of the trt cluster. The other end of the trt
cluster is deciphered by examining the metabolite profiles of the mutants ATEG_10075.1Δ
and ATEG_10076.1Δ that continue to produce terretonins (1 and 2, Figure 1).
From the trt3Δ, trt5Δ, trt6Δ, trt8Δ, and trt9Δ strains, the intermediates were purified by
semi-preparative HPLC. The intermediate from the trt5Δ strain decomposed to compound 7
(Figure 1). Its molecular formula was C25H38O6 (m/z calcd for C25H39O6 [M+H]+:
435.2741; found: 435.2747) which is identical to dihydroxyfarnesyl-DMOA, a shunt product
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in terretonin biosynthesis. This natural product was identified by Itoh et al. when trt4, trt2
and trt8 were co-expressed in A. oryzae.6 The trt8Δ strain accumulated one new metabolite
that can also be identified in trt1Δ. However, it decomposed to compound 8 (Figure 1, NMR
data shown in SI) during purification. The molecular formula of the unstable precursor was
C26H40O6 (m/z calcd for C26H41O6 [M+H]+: 449.2898; found: 449.2908). This molecule
contains one more CH2 fragment compared to the unstable intermediate from trt5Δ,
probably because the carboxylic acid group in the intermediate from trt5Δ has not been
methylated. Itoh et al. also noticed the decomposition of 13 (Figure 3) back to 7 upon long
exposure to solvents, indicating that 13 is less thermodynamically stable than 7. This may
explain why the unstable intermediates decomposed to 7 or 8 in our study.6
From the trt9Δ, trt3Δ, and trt6Δ deletant strains, three tetracyclic intermediates 9, 10 and 11
were isolated. Comparison of the 1H NMR and 13C NMR spectra with the published data
revealed that compound 9 is a known compound preterretonin A.20 The structures of two
new natural products 10 and 11 were determined by 1D and 2D NMR spectroscopy (Figure
1). Comparison of 13C NMR and HMBC spectra of both compounds 9 and 10 revealed that
a secondary hydroxyl carbon C3, which correlates with the C18 and C19 methyl groups in
the HMBC spectrum of 9, is oxidized to a carbonyl group in 10 (Table S3 and S4).
Compound 11 has a similar backbone compared to compound 10, only the D ring partial
structure of compound 11 is different from that of 10 (Figure 1). We named compounds 10
and 11 as preterrenoid and terrenoid, respectively.
Elucidation of the above intermediates in their respective mutant backgrounds enabled us to
propose a biosynthetic pathway for terretonin (Figure 3). The first step of the pathway is the
production of DMOA (7) by NR-PKS Trt4. The subsequent step is the prenylation of 7
catalyzed by the PT Trt2. Compound 7 (but no terretonins nor any other intermediates) was
identified from the trt2Δ strain (Figure 1). Coexpressing trt2 and trt4 in A. oryzae allowed
Itoh et al. to isolate the prenylated intermediate 13 (Figure 3).6 Thus, combination of the
above two pieces of data provides solid evidence for the prenylation step in terretonin
biosynthesis.
The prenylated precursor 13 is then modified via methylation by Trt5 to yield 14. Trt5
possesses a conserved methyltransferase domain and its sequence is 77% identical to AusD
(Table 1). However, the function of AusD was not specified, because no UV-active
intermediates were identified from the ausDΔ strain.7 Modifications of precursor 14 include
the epoxidation by Trt8 to 15 and cyclization by Trt1 to give the tetracyclic intermediate 16
(Figure 3). Only 7 accumulated in the trt2Δ and trt5Δ strains (Figure 1), suggesting that the
methylation of 7 occurs after prenylation. Compound 8 was purified from the decomposition
of an unstable intermediate identified in the trt1Δ and trt8Δ strains (Figure 1), indicating
that the carboxylic acid group in 13 has been esterified before epoxidation and cyclyzation
(Figure 3). Our speculation is also in accord with a recent study in which researchers
showed that methylation of precursor 13 is an essential step for cyclization of 15 to 16.20
Gene deletion experiments allowed us to identify several genes involved in the formation of
terretonin (1) via intermediate 16 (Figure 3). Previous labeling studies suggest that the
modifications of 16 involve an acyl shift to generate the olefinic moiety at C22, followed by
hydroxylation and intramolecular lactonization to yield a terretonin precursor 17 (Figure 3).5
Our study suggests that three genes, trt9, trt3 and trt6, are involved in this process. A
BLAST search revealed that Trt9 belongs to the short chain dehydrogenase family (Table 1).
Given that the 3-hydroxyl carbon in 9 is oxidized to a carbonyl in 10, this indicates that trt9
codes for a dehydrogenase that converts 9 to 10 (Figure 3). For Trt3, deletion of trt3
accumulates 10, indicating that trt3 is required for the C-hydroxylation at C16 of 10 to yield
11 (Figure 3). We isolated compound 11 from trt6Δ strain. We deduce that Trt6 is involved
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in converting 11 to 17 (Figure 3). The protein sequence of Trt6 is 57% similar to that of
SmP450-2, a P450 monooxygenase that mediates the lactone formation of GA9 and GA4 in
gibberellins biosynthesis in Sphaceloma manihoticola.21
We were able to identify terretonin C (2) but not terretonin (1) from the trt14Δ mutant. This
implies that Trt14 is likely to be involved in the transformation of 18 to terretonin (1) and
removal of trt14 may accumulate 18 that converts into terretonin C (2) via spontaneous
decarboxylation (Figure 1 and Figure 3). Finally the trt7Δ mutant is unable to produce either
terretonin (1) or terretonin C (2). A homology search reveals that the amino acid sequence of
Trt7 has a conserved phytanoyl-CoA dioxygenase domain (Table 1). The phytanoyl-CoA
dioxygenase catalyzes the initial α-hydroxylation of phytanoyl-CoA and converts it into 2-
hydroxylphytanoyl-CoA.22 The function of its homolog suggests that Trt7 might be
involved in the conversion from precursor 17 to 18, but elucidation of its specific function
requires further examination. In addition, genes in different loci in A. terreus may be
involved in this conversion.
In our study, we characterized one compact cluster for terretonin biosynthesis in A. terreus,
and protein homology analysis indicates that this cluster is closely related evolutionarily to
the two austinol clusters in A. nidulans (Table 1). In our previous work, we identified a
sequence that was located between AN11205.4 (ausK) and AN9256.4 (nucleotides 76655 to
77031 on linkage group VIII) which possesses high nucleotide identity with a portion in the
SAT domain of AN8383.4 (ausA) (P = 6.7 × 10-44) and proposed that the two austinol
clusters have originated from a single contiguous one.7 In this work, characterization of the
trt cluster in A. terreus for terretonin biosynthesis provides a piece of evidence for the
hypothesis that the trt cluster and aus clusters may share a common ancestor.
In conclusion, we have identified a cluster of 10 genes that is responsible for the
biosynthesis of terretonin. Aided by bioinformatic analysis and a series of targeted gene
deletions, LC/MS profile analysis and intermediate isolation and characterization, we have
proposed a biosynthetic pathway for terretonin.
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(A) Natural products isolated from this study. (B). HPLC profile of extracts of strains in the
cluster as detected by UV at total scan.
* This compound coelutes with 6 and decomposes to 8 upon isolation. † This compound
decomposes to 7 upon isolation.
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Comparison of the trt cluster and the aus clusters. Filled arrows represent genes that are
involved in either terretonin or austinol biosynthesis. Genes in open arrows are not involved.
Orthologous genes identified by homology BLAST analysis of their putative protein
sequence are shown in the same color (except black). Conserved genes within the trt cluster
and aus clusters are connected.
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Comparison of terretonin and austinol biosynthetic pathways. The pathway shown in A is
assumed to be shared by both terretonin and austinol biosynthesis. The double arrows
indicate more than one proteins are involved in this conversion. Boxed compounds are the
natural products that have been isolated in this or a previous study.6,7,20
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Table 1
Trt gene cluster and gene function prediction
Gene ATEG 100XX.1 BLASTP homologs Putative function
77 (trt1) AN9257.4 (ausL) Terpene cyclase
78 (trt2) AN9259.4 (ausN) Aromatic prenyltransferase
79 (trt3) AN8379.4 (ausB)
AN8381.4 (ausC)
Monooxygenase
80 (trt4) AN8383.4 (ausA) Polyketide synthase










84 (trt7) AN9246.4 (ausE) Phytanoyl-CoA dioxygenase
85 (trt8) AN11206.4 (ausM)
AN8378.4
Epoxidase
86 (trt9) Short chain dehydrogenase
87 (trt11) Not involved
88 (trt12) Not involved
89 (trt13) Not involved
The protein sequence similarity between genes in aus cluster and the corresponding genes in trt cluster is at least 50%.
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